nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—lung cancer—liver cancer	0.762	1	CtDrD
Vinorelbine—ABCB1—Sorafenib—liver cancer	0.00723	0.245	CbGbCtD
Vinorelbine—CYP2D6—Sorafenib—liver cancer	0.00681	0.231	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—liver cancer	0.00439	0.149	CbGbCtD
Vinorelbine—CYP3A4—Sorafenib—liver cancer	0.00433	0.147	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—liver cancer	0.00413	0.14	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—liver cancer	0.00263	0.0891	CbGbCtD
Vinorelbine—Vinblastine—JUN—liver cancer	0.0022	1	CrCbGaD
Vinorelbine—Stomatitis—Sorafenib—liver cancer	0.000502	0.00393	CcSEcCtD
Vinorelbine—Myasthenia—Doxorubicin—liver cancer	0.000501	0.00392	CcSEcCtD
Vinorelbine—Embolism—Doxorubicin—liver cancer	0.000491	0.00384	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Sorafenib—liver cancer	0.000487	0.00381	CcSEcCtD
Vinorelbine—Thrombosis—Epirubicin—liver cancer	0.000481	0.00376	CcSEcCtD
Vinorelbine—Lung disorder—Epirubicin—liver cancer	0.000481	0.00376	CcSEcCtD
Vinorelbine—Ileus—Epirubicin—liver cancer	0.000481	0.00376	CcSEcCtD
Vinorelbine—Blister—Epirubicin—liver cancer	0.000472	0.0037	CcSEcCtD
Vinorelbine—Bone marrow depression—Doxorubicin—liver cancer	0.000467	0.00365	CcSEcCtD
Vinorelbine—Connective tissue disorder—Sorafenib—liver cancer	0.000455	0.00356	CcSEcCtD
Vinorelbine—Thrombosis—Doxorubicin—liver cancer	0.000445	0.00348	CcSEcCtD
Vinorelbine—Ileus—Doxorubicin—liver cancer	0.000445	0.00348	CcSEcCtD
Vinorelbine—Lung disorder—Doxorubicin—liver cancer	0.000445	0.00348	CcSEcCtD
Vinorelbine—Blister—Doxorubicin—liver cancer	0.000437	0.00342	CcSEcCtD
Vinorelbine—Hyperaesthesia—Epirubicin—liver cancer	0.000434	0.00339	CcSEcCtD
Vinorelbine—Necrosis—Epirubicin—liver cancer	0.000434	0.00339	CcSEcCtD
Vinorelbine—Flushing—Sorafenib—liver cancer	0.000429	0.00336	CcSEcCtD
Vinorelbine—Cardiac disorder—Sorafenib—liver cancer	0.000429	0.00336	CcSEcCtD
Vinorelbine—Angiopathy—Sorafenib—liver cancer	0.00042	0.00328	CcSEcCtD
Vinorelbine—Immune system disorder—Sorafenib—liver cancer	0.000418	0.00327	CcSEcCtD
Vinorelbine—Injection site pain—Epirubicin—liver cancer	0.000417	0.00326	CcSEcCtD
Vinorelbine—Mediastinal disorder—Sorafenib—liver cancer	0.000417	0.00326	CcSEcCtD
Vinorelbine—Arrhythmia—Sorafenib—liver cancer	0.000413	0.00323	CcSEcCtD
Vinorelbine—Alopecia—Sorafenib—liver cancer	0.000409	0.0032	CcSEcCtD
Vinorelbine—Malnutrition—Sorafenib—liver cancer	0.000403	0.00315	CcSEcCtD
Vinorelbine—Erythema—Sorafenib—liver cancer	0.000403	0.00315	CcSEcCtD
Vinorelbine—Hyperaesthesia—Doxorubicin—liver cancer	0.000401	0.00314	CcSEcCtD
Vinorelbine—Necrosis—Doxorubicin—liver cancer	0.000401	0.00314	CcSEcCtD
Vinorelbine—Extravasation—Epirubicin—liver cancer	0.00039	0.00305	CcSEcCtD
Vinorelbine—Vasodilation—Epirubicin—liver cancer	0.000387	0.00303	CcSEcCtD
Vinorelbine—Vasodilation procedure—Epirubicin—liver cancer	0.000387	0.00303	CcSEcCtD
Vinorelbine—Injection site pain—Doxorubicin—liver cancer	0.000386	0.00302	CcSEcCtD
Vinorelbine—Anaemia—Sorafenib—liver cancer	0.000372	0.00291	CcSEcCtD
Vinorelbine—Angioedema—Sorafenib—liver cancer	0.000368	0.00288	CcSEcCtD
Vinorelbine—Extravasation—Doxorubicin—liver cancer	0.000361	0.00283	CcSEcCtD
Vinorelbine—Leukopenia—Sorafenib—liver cancer	0.00036	0.00282	CcSEcCtD
Vinorelbine—Blood bilirubin increased—Epirubicin—liver cancer	0.00036	0.00282	CcSEcCtD
Vinorelbine—Vasodilation procedure—Doxorubicin—liver cancer	0.000359	0.00281	CcSEcCtD
Vinorelbine—Vasodilation—Doxorubicin—liver cancer	0.000359	0.00281	CcSEcCtD
Vinorelbine—Creatinine increased—Epirubicin—liver cancer	0.000358	0.0028	CcSEcCtD
Vinorelbine—Cough—Sorafenib—liver cancer	0.000351	0.00275	CcSEcCtD
Vinorelbine—Gait disturbance—Epirubicin—liver cancer	0.000349	0.00273	CcSEcCtD
Vinorelbine—Hypertension—Sorafenib—liver cancer	0.000348	0.00272	CcSEcCtD
Vinorelbine—Myalgia—Sorafenib—liver cancer	0.000343	0.00268	CcSEcCtD
Vinorelbine—Arthralgia—Sorafenib—liver cancer	0.000343	0.00268	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00034	0.00266	CcSEcCtD
Vinorelbine—Pulmonary embolism—Epirubicin—liver cancer	0.00034	0.00266	CcSEcCtD
Vinorelbine—Injection site reaction—Epirubicin—liver cancer	0.000338	0.00265	CcSEcCtD
Vinorelbine—Blood bilirubin increased—Doxorubicin—liver cancer	0.000333	0.00261	CcSEcCtD
Vinorelbine—Creatinine increased—Doxorubicin—liver cancer	0.000331	0.00259	CcSEcCtD
Vinorelbine—Anaphylactic shock—Sorafenib—liver cancer	0.000329	0.00257	CcSEcCtD
Vinorelbine—Infection—Sorafenib—liver cancer	0.000327	0.00256	CcSEcCtD
Vinorelbine—Skin exfoliation—Epirubicin—liver cancer	0.000325	0.00254	CcSEcCtD
Vinorelbine—Gait disturbance—Doxorubicin—liver cancer	0.000323	0.00253	CcSEcCtD
Vinorelbine—Nervous system disorder—Sorafenib—liver cancer	0.000322	0.00252	CcSEcCtD
Vinorelbine—Thrombocytopenia—Sorafenib—liver cancer	0.000322	0.00252	CcSEcCtD
Vinorelbine—Aplastic anaemia—Epirubicin—liver cancer	0.00032	0.0025	CcSEcCtD
Vinorelbine—Skin disorder—Sorafenib—liver cancer	0.000319	0.0025	CcSEcCtD
Vinorelbine—Pulmonary embolism—Doxorubicin—liver cancer	0.000315	0.00247	CcSEcCtD
Vinorelbine—Anorexia—Sorafenib—liver cancer	0.000313	0.00245	CcSEcCtD
Vinorelbine—Injection site reaction—Doxorubicin—liver cancer	0.000313	0.00245	CcSEcCtD
Vinorelbine—Oesophagitis—Epirubicin—liver cancer	0.000311	0.00243	CcSEcCtD
Vinorelbine—Pulmonary oedema—Epirubicin—liver cancer	0.000303	0.00237	CcSEcCtD
Vinorelbine—Skin exfoliation—Doxorubicin—liver cancer	0.000301	0.00235	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000299	0.00234	CcSEcCtD
Vinorelbine—Aplastic anaemia—Doxorubicin—liver cancer	0.000296	0.00231	CcSEcCtD
Vinorelbine—Sepsis—Epirubicin—liver cancer	0.000295	0.00231	CcSEcCtD
Vinorelbine—Dyspnoea—Sorafenib—liver cancer	0.000293	0.00229	CcSEcCtD
Vinorelbine—Oesophagitis—Doxorubicin—liver cancer	0.000288	0.00225	CcSEcCtD
Vinorelbine—Phlebitis—Epirubicin—liver cancer	0.000287	0.00225	CcSEcCtD
Vinorelbine—Decreased appetite—Sorafenib—liver cancer	0.000286	0.00224	CcSEcCtD
Vinorelbine—Thrombophlebitis—Epirubicin—liver cancer	0.000285	0.00223	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000284	0.00222	CcSEcCtD
Vinorelbine—Fatigue—Sorafenib—liver cancer	0.000283	0.00222	CcSEcCtD
Vinorelbine—Constipation—Sorafenib—liver cancer	0.000281	0.0022	CcSEcCtD
Vinorelbine—Pain—Sorafenib—liver cancer	0.000281	0.0022	CcSEcCtD
Vinorelbine—Pulmonary oedema—Doxorubicin—liver cancer	0.00028	0.00219	CcSEcCtD
Vinorelbine—Hepatic failure—Epirubicin—liver cancer	0.000275	0.00215	CcSEcCtD
Vinorelbine—Sepsis—Doxorubicin—liver cancer	0.000273	0.00214	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Sorafenib—liver cancer	0.000269	0.0021	CcSEcCtD
Vinorelbine—Phlebitis—Doxorubicin—liver cancer	0.000265	0.00208	CcSEcCtD
Vinorelbine—Thrombophlebitis—Doxorubicin—liver cancer	0.000264	0.00207	CcSEcCtD
Vinorelbine—Urticaria—Sorafenib—liver cancer	0.000261	0.00204	CcSEcCtD
Vinorelbine—Abdominal pain—Sorafenib—liver cancer	0.00026	0.00203	CcSEcCtD
Vinorelbine—Body temperature increased—Sorafenib—liver cancer	0.00026	0.00203	CcSEcCtD
Vinorelbine—Dermatitis bullous—Epirubicin—liver cancer	0.000259	0.00202	CcSEcCtD
Vinorelbine—Hepatic failure—Doxorubicin—liver cancer	0.000254	0.00199	CcSEcCtD
Vinorelbine—Cardiac failure—Epirubicin—liver cancer	0.000253	0.00198	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Epirubicin—liver cancer	0.000252	0.00197	CcSEcCtD
Vinorelbine—Lethargy—Epirubicin—liver cancer	0.000252	0.00197	CcSEcCtD
Vinorelbine—Hyponatraemia—Epirubicin—liver cancer	0.000248	0.00194	CcSEcCtD
Vinorelbine—Hypersensitivity—Sorafenib—liver cancer	0.000242	0.0019	CcSEcCtD
Vinorelbine—Dermatitis bullous—Doxorubicin—liver cancer	0.000239	0.00187	CcSEcCtD
Vinorelbine—Asthenia—Sorafenib—liver cancer	0.000236	0.00185	CcSEcCtD
Vinorelbine—Cardiac failure—Doxorubicin—liver cancer	0.000234	0.00183	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—liver cancer	0.000233	0.00183	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—liver cancer	0.000233	0.00183	CcSEcCtD
Vinorelbine—Pruritus—Sorafenib—liver cancer	0.000233	0.00182	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—liver cancer	0.000232	0.00181	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—liver cancer	0.00023	0.0018	CcSEcCtD
Vinorelbine—Diarrhoea—Sorafenib—liver cancer	0.000225	0.00176	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000223	0.00174	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—liver cancer	0.000218	0.00171	CcSEcCtD
Vinorelbine—Dizziness—Sorafenib—liver cancer	0.000217	0.0017	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—liver cancer	0.000214	0.00168	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—liver cancer	0.000214	0.00167	CcSEcCtD
Vinorelbine—Pancreatitis—Epirubicin—liver cancer	0.000209	0.00164	CcSEcCtD
Vinorelbine—Vomiting—Sorafenib—liver cancer	0.000209	0.00164	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—liver cancer	0.000208	0.00163	CcSEcCtD
Vinorelbine—Rash—Sorafenib—liver cancer	0.000207	0.00162	CcSEcCtD
Vinorelbine—Dermatitis—Sorafenib—liver cancer	0.000207	0.00162	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000206	0.00161	CcSEcCtD
Vinorelbine—Headache—Sorafenib—liver cancer	0.000206	0.00161	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—liver cancer	0.000203	0.00159	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—liver cancer	0.000202	0.00158	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—liver cancer	0.0002	0.00156	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—liver cancer	0.000198	0.00155	CcSEcCtD
Vinorelbine—Nausea—Sorafenib—liver cancer	0.000195	0.00153	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—liver cancer	0.000194	0.00152	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—liver cancer	0.000193	0.00151	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—liver cancer	0.000193	0.00151	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—liver cancer	0.000192	0.0015	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—liver cancer	0.00019	0.00149	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—liver cancer	0.00019	0.00149	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—liver cancer	0.000188	0.00147	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—liver cancer	0.000187	0.00146	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—liver cancer	0.000186	0.00145	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—liver cancer	0.000185	0.00145	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—liver cancer	0.00018	0.00141	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—liver cancer	0.000179	0.0014	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—liver cancer	0.000178	0.00139	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—liver cancer	0.000177	0.00139	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—liver cancer	0.000176	0.00138	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—liver cancer	0.000176	0.00138	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000173	0.00135	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—liver cancer	0.000172	0.00134	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—liver cancer	0.00017	0.00133	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—liver cancer	0.000168	0.00131	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000167	0.0013	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—liver cancer	0.000164	0.00129	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—liver cancer	0.000159	0.00124	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—liver cancer	0.000159	0.00124	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—liver cancer	0.000157	0.00123	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—liver cancer	0.000155	0.00122	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—liver cancer	0.000155	0.00121	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—liver cancer	0.000154	0.00121	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—liver cancer	0.000154	0.00121	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—liver cancer	0.000153	0.0012	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—liver cancer	0.000151	0.00118	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—liver cancer	0.000149	0.00116	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—liver cancer	0.000149	0.00116	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—liver cancer	0.000147	0.00115	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—liver cancer	0.000147	0.00115	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—liver cancer	0.000144	0.00113	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—liver cancer	0.000144	0.00112	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—liver cancer	0.000143	0.00112	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—liver cancer	0.000143	0.00112	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—liver cancer	0.000141	0.00111	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—liver cancer	0.00014	0.00109	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—liver cancer	0.000138	0.00108	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—liver cancer	0.000138	0.00108	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—liver cancer	0.000138	0.00108	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—liver cancer	0.000138	0.00108	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—liver cancer	0.000134	0.00105	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—liver cancer	0.000134	0.00105	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—liver cancer	0.000133	0.00104	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—liver cancer	0.000133	0.00104	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—liver cancer	0.000132	0.00103	CcSEcCtD
Vinorelbine—Cough—Epirubicin—liver cancer	0.00013	0.00102	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—liver cancer	0.000128	0.00101	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—liver cancer	0.000128	0.001	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—liver cancer	0.000127	0.000996	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—liver cancer	0.000127	0.000992	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—liver cancer	0.000127	0.000992	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—liver cancer	0.000127	0.000992	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000126	0.000985	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—liver cancer	0.000125	0.00098	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—liver cancer	0.000124	0.000972	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—liver cancer	0.000124	0.000968	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—liver cancer	0.000123	0.000965	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—liver cancer	0.000122	0.000952	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—liver cancer	0.000121	0.000951	CcSEcCtD
Vinorelbine—Infection—Epirubicin—liver cancer	0.000121	0.000944	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—liver cancer	0.00012	0.00094	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—liver cancer	0.000119	0.000932	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—liver cancer	0.000119	0.000931	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—liver cancer	0.000119	0.000931	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—liver cancer	0.000119	0.000928	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—liver cancer	0.000118	0.000923	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—liver cancer	0.000117	0.000918	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—liver cancer	0.000117	0.000918	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—liver cancer	0.000117	0.000918	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000116	0.000911	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—liver cancer	0.000116	0.000907	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—liver cancer	0.000116	0.000906	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—liver cancer	0.000113	0.000888	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—liver cancer	0.000112	0.00088	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—liver cancer	0.000112	0.000874	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000111	0.000866	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—liver cancer	0.00011	0.000863	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—liver cancer	0.00011	0.000861	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—liver cancer	0.00011	0.000858	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—liver cancer	0.000109	0.000854	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—liver cancer	0.000109	0.000854	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—liver cancer	0.000108	0.000848	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—liver cancer	0.000107	0.000838	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—liver cancer	0.000106	0.000826	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—liver cancer	0.000105	0.000822	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000105	0.000821	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—liver cancer	0.000105	0.00082	CcSEcCtD
Vinorelbine—Pain—Epirubicin—liver cancer	0.000104	0.000813	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—liver cancer	0.000104	0.000813	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000102	0.000801	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—liver cancer	0.000101	0.00079	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—liver cancer	0.0001	0.000784	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—liver cancer	0.0001	0.000783	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—liver cancer	9.93e-05	0.000777	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—liver cancer	9.77e-05	0.000765	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—liver cancer	9.7e-05	0.000759	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—liver cancer	9.69e-05	0.000758	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—liver cancer	9.65e-05	0.000755	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—liver cancer	9.61e-05	0.000752	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—liver cancer	9.61e-05	0.000752	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—liver cancer	9.6e-05	0.000752	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—liver cancer	9.6e-05	0.000752	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—liver cancer	9.26e-05	0.000725	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—liver cancer	9.19e-05	0.000719	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—liver cancer	8.95e-05	0.0007	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—liver cancer	8.93e-05	0.000699	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—liver cancer	8.88e-05	0.000695	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—liver cancer	8.88e-05	0.000695	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—liver cancer	8.71e-05	0.000682	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—liver cancer	8.59e-05	0.000673	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—liver cancer	8.31e-05	0.00065	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—liver cancer	8.28e-05	0.000648	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—liver cancer	8.06e-05	0.000631	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—liver cancer	8.03e-05	0.000629	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—liver cancer	7.95e-05	0.000622	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—liver cancer	7.72e-05	0.000604	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—liver cancer	7.69e-05	0.000602	CcSEcCtD
Vinorelbine—Rash—Epirubicin—liver cancer	7.66e-05	0.000599	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—liver cancer	7.65e-05	0.000599	CcSEcCtD
Vinorelbine—Headache—Epirubicin—liver cancer	7.61e-05	0.000596	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—liver cancer	7.43e-05	0.000582	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—liver cancer	7.21e-05	0.000565	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—liver cancer	7.15e-05	0.000559	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—liver cancer	7.09e-05	0.000555	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—liver cancer	7.08e-05	0.000554	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—liver cancer	7.04e-05	0.000551	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—liver cancer	6.68e-05	0.000522	CcSEcCtD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	4.22e-05	0.000536	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PCNA—liver cancer	4.22e-05	0.000535	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	4.18e-05	0.000529	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTA2—liver cancer	4.13e-05	0.000523	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—PCNA—liver cancer	4.12e-05	0.000523	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—PPARA—liver cancer	4.09e-05	0.000519	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—HMOX1—liver cancer	4.07e-05	0.000516	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—H2AFX—liver cancer	4.03e-05	0.000511	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—PPARA—liver cancer	4e-05	0.000508	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGF2—liver cancer	3.99e-05	0.000506	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TERT—liver cancer	3.98e-05	0.000505	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTA1—liver cancer	3.98e-05	0.000505	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—NAT2—liver cancer	3.94e-05	0.000499	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	3.92e-05	0.000498	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	3.88e-05	0.000492	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	3.87e-05	0.000491	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PCNA—liver cancer	3.77e-05	0.000478	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—liver cancer	3.68e-05	0.000466	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF2—liver cancer	3.65e-05	0.000463	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TERT—liver cancer	3.64e-05	0.000462	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GGT1—liver cancer	3.6e-05	0.000457	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—PPARA—liver cancer	3.59e-05	0.000456	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—F2—liver cancer	3.56e-05	0.000451	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—F2—liver cancer	3.56e-05	0.000451	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	3.52e-05	0.000446	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	3.47e-05	0.00044	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	3.45e-05	0.000438	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—F2—liver cancer	3.44e-05	0.000436	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—F2—liver cancer	3.33e-05	0.000422	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	3.3e-05	0.000419	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—liver cancer	3.29e-05	0.000417	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—PPARA—liver cancer	3.29e-05	0.000417	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1B—liver cancer	3.26e-05	0.000413	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—F2—liver cancer	3.26e-05	0.000413	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ALB—liver cancer	3.25e-05	0.000412	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ALB—liver cancer	3.25e-05	0.000412	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTP1—liver cancer	3.24e-05	0.00041	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	3.23e-05	0.000409	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	3.19e-05	0.000405	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—HPGDS—liver cancer	3.15e-05	0.000399	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ALB—liver cancer	3.14e-05	0.000398	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—liver cancer	3.11e-05	0.000394	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	3.09e-05	0.000391	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	3.08e-05	0.00039	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CASP3—liver cancer	3.08e-05	0.00039	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL2—liver cancer	3.07e-05	0.00039	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—liver cancer	3.05e-05	0.000386	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ALB—liver cancer	3.04e-05	0.000386	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP2—liver cancer	3.02e-05	0.000383	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP2—liver cancer	3.02e-05	0.000383	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	3.02e-05	0.000382	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1A—liver cancer	3.01e-05	0.000381	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ALB—liver cancer	2.98e-05	0.000377	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTM1—liver cancer	2.97e-05	0.000377	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	2.95e-05	0.000374	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	2.95e-05	0.000374	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—RAF1—liver cancer	2.94e-05	0.000373	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—RAF1—liver cancer	2.94e-05	0.000373	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	2.93e-05	0.000372	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—F2—liver cancer	2.92e-05	0.000371	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP2—liver cancer	2.92e-05	0.00037	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1B—liver cancer	2.91e-05	0.000369	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—RAF1—liver cancer	2.84e-05	0.00036	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP2—liver cancer	2.82e-05	0.000358	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	2.82e-05	0.000357	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	2.79e-05	0.000354	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—liver cancer	2.79e-05	0.000353	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	2.78e-05	0.000353	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—liver cancer	2.78e-05	0.000352	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP2—liver cancer	2.76e-05	0.00035	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—RAF1—liver cancer	2.75e-05	0.000349	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—liver cancer	2.72e-05	0.000345	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.7e-05	0.000342	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.69e-05	0.000341	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1A—liver cancer	2.69e-05	0.000341	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—F2—liver cancer	2.67e-05	0.000339	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ALB—liver cancer	2.67e-05	0.000339	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	2.65e-05	0.000336	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—liver cancer	2.61e-05	0.000331	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—liver cancer	2.57e-05	0.000326	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	2.57e-05	0.000325	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	2.53e-05	0.000321	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—liver cancer	2.49e-05	0.000316	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—liver cancer	2.49e-05	0.000316	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.49e-05	0.000316	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP2—liver cancer	2.48e-05	0.000314	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.47e-05	0.000313	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ALB—liver cancer	2.44e-05	0.00031	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—RAF1—liver cancer	2.42e-05	0.000306	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—liver cancer	2.41e-05	0.000306	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—liver cancer	2.4e-05	0.000304	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GGT1—liver cancer	2.36e-05	0.000299	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—liver cancer	2.35e-05	0.000299	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	2.32e-05	0.000295	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTNNB1—liver cancer	2.31e-05	0.000293	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTNNB1—liver cancer	2.31e-05	0.000293	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—liver cancer	2.3e-05	0.000292	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	2.28e-05	0.000289	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.28e-05	0.000289	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP2—liver cancer	2.27e-05	0.000287	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—liver cancer	2.24e-05	0.000284	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—UGDH—liver cancer	2.24e-05	0.000284	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CTNNB1—liver cancer	2.23e-05	0.000283	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—liver cancer	2.23e-05	0.000283	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1A—liver cancer	2.23e-05	0.000282	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—RAF1—liver cancer	2.21e-05	0.00028	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—liver cancer	2.21e-05	0.00028	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTNNB1—liver cancer	2.16e-05	0.000274	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	2.15e-05	0.000273	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CTNNB1—liver cancer	2.12e-05	0.000268	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—liver cancer	2.12e-05	0.000268	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—UGDH—liver cancer	2.11e-05	0.000267	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—liver cancer	2.11e-05	0.000267	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EPT1—liver cancer	2.1e-05	0.000267	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	2.09e-05	0.000265	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—liver cancer	2.07e-05	0.000262	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1A—liver cancer	2.04e-05	0.000258	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TAT—liver cancer	1.99e-05	0.000253	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EPT1—liver cancer	1.98e-05	0.000251	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—liver cancer	1.94e-05	0.000247	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	1.92e-05	0.000244	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	1.92e-05	0.000243	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CTNNB1—liver cancer	1.9e-05	0.000241	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—liver cancer	1.89e-05	0.000239	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TAT—liver cancer	1.88e-05	0.000238	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—liver cancer	1.85e-05	0.000234	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	1.84e-05	0.000234	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—liver cancer	1.83e-05	0.000232	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	1.82e-05	0.00023	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTNNB1—liver cancer	1.74e-05	0.00022	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	1.69e-05	0.000214	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—liver cancer	1.69e-05	0.000214	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	1.55e-05	0.000196	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	1.52e-05	0.000193	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—liver cancer	1.52e-05	0.000192	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	1.48e-05	0.000187	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	1.47e-05	0.000187	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	1.46e-05	0.000186	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	1.43e-05	0.000181	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.42e-05	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.4e-05	0.000177	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—liver cancer	1.39e-05	0.000176	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UGDH—liver cancer	1.38e-05	0.000175	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CPT1B—liver cancer	1.36e-05	0.000172	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GLUL—liver cancer	1.36e-05	0.000172	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NR1H4—liver cancer	1.31e-05	0.000166	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EPT1—liver cancer	1.3e-05	0.000164	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	1.29e-05	0.000163	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA3—liver cancer	1.28e-05	0.000163	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GLUL—liver cancer	1.28e-05	0.000162	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CPT1B—liver cancer	1.28e-05	0.000162	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.24e-05	0.000157	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NR1H4—liver cancer	1.23e-05	0.000156	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TAT—liver cancer	1.23e-05	0.000156	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA3—liver cancer	1.21e-05	0.000154	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	1.19e-05	0.00015	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	1.18e-05	0.00015	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA4—liver cancer	1.18e-05	0.000149	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA2—liver cancer	1.15e-05	0.000145	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA4—liver cancer	1.11e-05	0.00014	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA1—liver cancer	1.1e-05	0.00014	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	1.1e-05	0.00014	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	1.1e-05	0.000139	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NAT2—liver cancer	1.09e-05	0.000139	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA2—liver cancer	1.08e-05	0.000137	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALDOB—liver cancer	1.05e-05	0.000133	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA1—liver cancer	1.04e-05	0.000132	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NAT2—liver cancer	1.03e-05	0.000131	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.01e-05	0.000128	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CRABP1—liver cancer	9.99e-06	0.000127	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	9.99e-06	0.000127	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDOB—liver cancer	9.87e-06	0.000125	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	9.74e-06	0.000123	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CRABP1—liver cancer	9.42e-06	0.000119	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HPGDS—liver cancer	8.73e-06	0.000111	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CPT1B—liver cancer	8.35e-06	0.000106	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GLUL—liver cancer	8.35e-06	0.000106	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HPGDS—liver cancer	8.23e-06	0.000104	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	8.22e-06	0.000104	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NR1H4—liver cancer	8.05e-06	0.000102	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA3—liver cancer	7.92e-06	0.0001	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSMA4—liver cancer	7.79e-06	9.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSMD10—liver cancer	7.79e-06	9.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GOT2—liver cancer	7.57e-06	9.6e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	7.42e-06	9.41e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSMD10—liver cancer	7.34e-06	9.3e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSMA4—liver cancer	7.34e-06	9.3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA4—liver cancer	7.24e-06	9.18e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GOT2—liver cancer	7.14e-06	9.05e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2E1—liver cancer	7.12e-06	9.03e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA2—liver cancer	7.06e-06	8.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA1—liver cancer	6.81e-06	8.63e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAT2—liver cancer	6.73e-06	8.54e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.71e-06	8.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2E1—liver cancer	6.71e-06	8.51e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYCS—liver cancer	6.66e-06	8.45e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GOT1—liver cancer	6.54e-06	8.29e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GGT1—liver cancer	6.54e-06	8.29e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDOB—liver cancer	6.45e-06	8.18e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYCS—liver cancer	6.28e-06	7.96e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GGT1—liver cancer	6.16e-06	7.81e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GOT1—liver cancer	6.16e-06	7.81e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CRABP1—liver cancer	6.16e-06	7.81e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—liver cancer	5.87e-06	7.45e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMOX1—liver cancer	5.79e-06	7.34e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—liver cancer	5.53e-06	7.02e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMOX1—liver cancer	5.46e-06	6.92e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—liver cancer	5.4e-06	6.84e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPGDS—liver cancer	5.38e-06	6.82e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1A1—liver cancer	5.12e-06	6.49e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—liver cancer	5.09e-06	6.45e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1A1—liver cancer	4.82e-06	6.11e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSMA4—liver cancer	4.8e-06	6.08e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSMD10—liver cancer	4.8e-06	6.08e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—liver cancer	4.77e-06	6.05e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARA—liver cancer	4.68e-06	5.93e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GOT2—liver cancer	4.67e-06	5.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—liver cancer	4.49e-06	5.7e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARA—liver cancer	4.41e-06	5.59e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.39e-06	5.56e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYCS—liver cancer	4.1e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GGT1—liver cancer	4.03e-06	5.11e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GOT1—liver cancer	4.03e-06	5.11e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—liver cancer	4.01e-06	5.08e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARG—liver cancer	3.87e-06	4.9e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—liver cancer	3.78e-06	4.79e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARG—liver cancer	3.64e-06	4.62e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—liver cancer	3.62e-06	4.59e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMOX1—liver cancer	3.57e-06	4.52e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CD—liver cancer	3.52e-06	4.47e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALB—liver cancer	3.48e-06	4.41e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—liver cancer	3.32e-06	4.22e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CD—liver cancer	3.32e-06	4.21e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALB—liver cancer	3.28e-06	4.15e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.15e-06	4e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CB—liver cancer	3.07e-06	3.89e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—liver cancer	2.94e-06	3.73e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CB—liver cancer	2.89e-06	3.67e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARA—liver cancer	2.88e-06	3.66e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.47e-06	3.13e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARG—liver cancer	2.38e-06	3.02e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.17e-06	2.75e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALB—liver cancer	2.14e-06	2.72e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.89e-06	2.4e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—liver cancer	1.87e-06	2.37e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.76e-06	2.24e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—liver cancer	1.53e-06	1.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—liver cancer	1.44e-06	1.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.15e-06	1.46e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—liver cancer	9.42e-07	1.19e-05	CbGpPWpGaD
